(Q47957009)

7 February 2018

title

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus (English)

1 reference

7 February 2018

0 references

1 reference

1 reference

1 reference

1 reference

1 reference

3

1 reference

7 February 2018

Maria Rita Gismondo

6

1 reference

7 February 2018

Rino Rappuoli

8

object named as

Rino Rappuoli

1 reference

7 February 2018

9

Antonio Lanzavecchia

1 reference

7 February 2018

2

Stephan Becker

1 reference

7 February 2018

Brian R. Murphy

7

object named as

Brian R Murphy

1 reference

7 February 2018

author name string

Elisabetta Traggiai

1

1 reference

7 February 2018

Larissa Kolesnikova

4

1 reference

7 February 2018

Yasushi Uematsu

5

1 reference

7 February 2018

language of work or name

English

0 references

publication date

11 July 2004

1 reference

7 February 2018

published in

Nature Medicine

1 reference

7 February 2018

volume

10

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

page(s)

871-875

1 reference

7 February 2018

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

cites work

1 reference

12 December 2020

Primary respiratory syncytial virus infection in mice

1 reference

12 December 2020

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

1 reference

12 December 2020

Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein

1 reference

12 December 2020

Identification of severe acute respiratory syndrome in Canada

1 reference

12 December 2020

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

1 reference

12 December 2020

Passive immunity in prevention and treatment of infectious diseases

1 reference

12 December 2020

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

12 December 2020

A human myeloma cell line suitable for the generation of human monoclonal antibodies

1 reference

12 December 2020

Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Maintenance of serological memory by polyclonal activation of human memory B cells

1 reference

12 December 2020

Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model

1 reference

12 December 2020

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

1 reference

12 December 2020

On the development of immunity to diphtheria and tetanus in animals

1 reference

12 December 2020

kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire

1 reference

12 December 2020

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

12 December 2020

Antigen-specific interaction between T and B cells

1 reference

12 December 2020

EB virus-induced B lymphocyte cell lines producing specific antibody

1 reference

12 December 2020

https://api.crossref.org/works/10.1038%2FNM1080

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NM1080

1 reference

7 February 2018

PMC publication ID

7095806

0 references

1 reference

7 February 2018